BioCatalystWatch
XFORWorkspace / XFOR / OverviewCompany library
X4 Pharmaceuticals, Inc logo

X4 Pharmaceuticals, Inc

X4 Pharmaceuticals, Inc (XFOR)

Website

Price
Market cap
Next catalystExpected Q4 2026Mavorixafor — 4WARD; prior chronic-neutropenia study history · Enrollment completionCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Mavorixafor

Small molecule

CXCR4

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Mavorixafor

Small molecule

CXCR4

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Mavorixafor

Small molecule

CXCR4

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Mavorixafor

Small molecule

CXCR4

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Approved / commercial

History / paused

Mavorixafor

Small molecule

CXCR4

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

XFOR PR & News

XFOR SEC archive